PNC Financial Services Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31
Closed -$1.08K 4993
2024
Q1
$1.08K Hold
31
﹤0.01% 4352
2023
Q4
$1.18K Buy
+31
New +$664 ﹤0.01% 4287

Other funds holding INBX

PNC Financial Services Group's INBX Position: Q2 2024 in Review

PNC Financial Services Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 31 shares — an estimated $1.08K sold.

PNC Financial Services Group first reported a position in INBX in Q4 2023 and held it in 2 quarters. The position peaked at $1.18K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • PNC Financial Services Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 31 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.08K.
  • PNC Financial Services Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • PNC Financial Services Group's Inhibrx, Inc. Common Stock position peaked at $1.18K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.